Biopharma – Talk Bio

Biopharma Briefing: Q1 Trends and Updates

6 days ago talkbio0Tagged ASCO preview, Biopharma, gene therapy, Q1 trends

biopharma; Q1 trends; gene therapy; ASCO preview

Regeneron Licenses Hansoh’s GLP-1/GIP Obesity Drug to Compete with Zepbound

6 days ago talkbio0Tagged Biopharma, eli lilly, GLP-1/GIP receptor agonist, Hansoh Pharmaceuticals, HS-20094, Licensing Deal, Obesity, Regeneron, Zepbound

Regeneron; Hansoh Pharmaceuticals; HS-20094; GLP-1/GIP receptor agonist; obesity drug; Zepbound; Eli Lilly; obesity treatment; licensing deal; biopharma

Sanofi to Acquire Blueprint Medicines for Up to $9.5 Billion, Expanding Immunology Focus

6 days ago talkbio0Tagged Acquisition, Ayvakit, Biopharma, Blueprint Medicines, elenestinib, Immunology, Infrequent, Mastocytosis, Systemic, pipeline, sanofi

Sanofi; Blueprint Medicines; acquisition; immunology; systemic mastocytosis; Ayvakit; elenestinib; rare diseases; biopharma; pipeline

Exit Strategy: Biopharma Professionals Consider Opportunities Outside Industry and US

2 weeks ago talkbio0Tagged Biological Science Disciplines, Biopharma, biopharma survey, biotech careers, Drug Industry, employment, Industry, Market, Transition Mutation, trends qualifier, U.S.

biopharma talent; job market trends; industry transition; employment outside US; biopharma survey 2025; life sciences employment; biotech careers; pharmaceutical industry

Spotlight on LGBTQ+ Leaders Driving Change in Life Sciences

3 weeks ago talkbio0Tagged Biological Science Disciplines, Biopharma, Diversity, Fellows, GUTC, Health Workforce, Inclusion, Leadership, LGBTQ+ professionals, Monthly (qualifier value), philanthropy

LGBTQ+ professionals; life sciences; biopharma; leadership; Diversity and Inclusion; Health Workforce; GUTC Fellows; philanthropy; Pride Month

Bristol Myers CEO: America’s Biopharma Leadership Not Guaranteed

4 weeks ago talkbio0Tagged Americas, Biopharma, CEO, Chris Boerner, dealmaking, global competitiveness, Growth, innovation, Myers, squibb

Bristol Myers Squibb; CEO; Chris Boerner; biopharma; Americas; global competitiveness; dealmaking; innovation; growth portfolio

ElevAAte and the push for East Asian American leaders in biopharma

1 month ago talkbio0Tagged Asian Americans, Biopharma, East Asian American, East Asian Americans, ElevAAte, Ken Song, leaders, Leadership, Mentorships

ElevAAte, biopharma, East Asian American, Leadership, leaders, Asian Americans, Mentorships, East Asian Americans, Ken Song

Biopharma Layoff Trends in Q1 2025 and Outlook for Q2

2 months ago talkbio0Tagged Biopharma, Biopharma layoffs, Changing, Industry, Legal patent, Pharma, pharmaceutical employment, Q1 2025, Q2 layoff, regulatory, restructuring

Biopharma layoffs, Q1 2025 layoffs, biotech job cuts, pharma workforce reductions, restructuring, patent cliffs, regulatory challenges, Q2 layoff forecast, pharmaceutical employment trends, biopharma industry changes.